Specific Type of Lymphoma Linked by FDA to Breast Implants
The FDA has linked the use of breast implants, especially ones with a textured cover, with a rare type of cancer, anaplastic large-cell lymphoma (ALCL). Indeed the causation is so clear that they have named it BIA-ALCL, that is breast implant associated ALCL. Nine deaths were among the reports studied.
Some 359 reports have been made to the FDA of BIA-ALCL. The implants had been filled both with saline and silicone gel. What stood out in the study was the increased incidence of ALCL in women using textured implants versus those with smooth covers: 312 of the reports involved textured implants.
A textured cover was adopted in the belief that it would hold the implant in place and prevent contracture problems. Manufacturers of textured implants include Mentor, Allergan and Sientra.
The FDA reports listed signs and symptoms of possible development of ALCL, including lumps, pain, swelling and lack of symmetry between the two implants. It cautions removal but recommends medical checkups.
Our firm has had considerable experience in litigation breast implant injury cases. These involved a connective tissue disease due to leaking silicone gel. We will promptly investigate every call and email we get in the newly revealed area. Contact us at (888) 260-0473.